allergic rhinitis
Conditions
Interventions
Drug group:The drug group received oral loratadine 10 mg once/day for 8 weeks.
Xuanfei-Tongqiao acupuncture combined with sphenopalatine ganglion apuncture group:Xuanfei-Tongqiao acupuncture combined with sphenopalatine ganglion took the same acupoints, needling method and treat
Sphenopalatine ganglion acupuncture group:In Sphenopalatine ganglion acupuncture group, 0.35mm×55mm sterile acupuncture needles were used, and the needles were inserted into the bone gap from the lowe
Xuanfei-Tongqiao acupuncture group:In Xuanfei-Tongqiao acupuncture group, 0.30×40mm Huatuo brand single-use sterile acupuncture needles were used, and the acupoints of Yingxiang(LI20) Shangyingxiang (
Sponsors
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Patients with perennial moderate-to-severe AR who meet the diagnosis of Chinese and Western medicine and have a total score of 8 to 12 for symptoms and signs; 2) Patients who have signed the informed consent; 3) Age between 18 and 65 years old; 4) No history of asthma attack or other allergic diseases within 6 months before enrollment; 5) No use of glucocorticosteroids in the week before enrollment and no use of H1 antihistamines leukotriene receptor antagonists and other antiallergic drugs in the week before enrollment.
Exclusion criteria
Exclusion criteria: 1) Those with vasomotor rhinitis non-allergic rhinitis with eosinophilia syndrome infectious rhinitis hormonal rhinitis drug-induced rhinitis and other related rhinitis; 2) Combined with severe organ and tissue dysfunction tumor infectious diseases psychiatric patients; 3) Women during pregnancy; 4) Those who are unable to cooperate with the treatment or whose data are incomplete which may affect the judgment of the efficacy of the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total nasal symptom score TNSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| total non-nasal symptom score,TNNSS;Rhinoconjunctivitis Quality of Life Questionnaire,RQLQ;Visual Analogue Scale,VAS;IgA\IgG\IgE\IL-17\IL-10\IL-4; | — |
Countries
China
Contacts
Public ContactPengYongJun
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed